An E-platform for Learners

Day: September 15, 2025

Lupin Secures USFDA Approval for Complex Risperidone Injectable, Validating its Nanomi Technology Platform

Lupin Secures USFDA Approval for Complex Risperidone Injectable, Validating its Nanomi Technology Platform

Pharm'Up

Global pharma major Lupin Limited has announced a significant regulatory milestone, having received final approval from the...

Caplin Steriles Secures Landmark USFDA Approval for Milrinone Lactate in Infusion Bags, Boosting Generic Portfolio

Caplin Steriles Secures Landmark USFDA Approval for Milrinone Lactate in Infusion Bags, Boosting Generic Portfolio

Pharm'Up

Caplin Steriles Limited, a prominent subsidiary of Caplin Point Laboratories Limited, has announced a significant achievement with...

Sandoz Triumphs in Patent Dispute, Secures Q4 2026 US Launch for Eylea® Biosimilar

Sandoz Triumphs in Patent Dispute, Secures Q4 2026 US Launch for Eylea® Biosimilar

Pharm'Up

In a landmark victory for patient access and biosimilar competition, Sandoz, a global leader in generic and...

Novartis Expands Cardiovascular Portfolio with Acquisition of Tourmaline Bio, Adds Phase 3-Ready Asset Pacibekitug

Novartis Expands Cardiovascular Portfolio with Acquisition of Tourmaline Bio, Adds Phase 3-Ready Asset Pacibekitug

Pharm'Up

Novartis has announced a definitive agreement to acquire Tourmaline Bio, a New York-based, publicly traded biopharmaceutical company....

Glenmark Kicks Off Pivotal Phase 3 Trial for Envafolimab, a Novel Subcutaneous Cancer Therapy for Lung Cancer

Glenmark Kicks Off Pivotal Phase 3 Trial for Envafolimab, a Novel Subcutaneous Cancer Therapy for Lung Cancer

Pharm'Up

In a significant step forward for oncology research, Glenmark Pharmaceuticals has announced the initiation of a multi-country...